What is the physical appearance and state of the powder?

The product is a solid, white or off-white crystalline powder that is not volatile.

Where is the company located and what is their export experience?

Located in Beijing, China, the company has been exporting since 2010 and serves markets globally including North America and Europe.

99% Raw Material Tetramisole Hydrochloride Pharmaceutical Powder CAS 5086-74-8

Name: 99% Raw Material Tetramisole Hydrochloride Pharmaceutical Powder CAS 5086-74-8
Brand: Beijing Mesochem Technology Co., Ltd.
SKU: 1966103915

Beijing, ChinaBeijing Mesochem Technology Co., Ltd.

US$1.00-10.00

1 g

Product profile

Customization

Available

Function

Hormones and Regulation of Endocrine Function of Drug, Vitamins and Minerals Deficiency Drug, Nutritional Therapeutics, Antineoplastic, Antibiotic and Antimicrobial Agents, Antiparasitic, Original Drug Resistant Microbes, Antipyretic Analgesic and Non-Steroidal Anti-Inflammatory Analgesic, Immune System Drugs, Specialist Drugs, Regulating Water and Salt, Electrolyte and Acid-Base Balance of Medicine, Drug Detoxification, Diagnostic Agents, Anesthetic and Adjuvant, Nervous System Drugs, Blood System Agents, Enzymes and Other Biochemical, Drug Treatment of Mental Disorder, Visceral System Medication, Central Nervous System Agents, Cardiovascular Agents, Anti-Allergic Agents, Urinary System Agents, Antidote, Respiratory System Agents, Disinfectant and Preservatives

Certification

Reach

Model NO.

5086-74-8

Grade Standard

Medicine Grade

Type

Chemical Reagent

State

Solid

Volatile

Not Volatile

Molecular Formula

C17h14brn3o2s

CAS Registry Number

5086-74-8

Form

Powder

Assay

99%

Color

White

Transport Package

Standard Export Package

Specification

GMP

Trademark

Mesochem

Origin

China

HS Code

2934999090

Production Capacity

10kg/Month

Key features

High Purity Assay: Assay on dry basis reaches 101.2%, exceeding the standard of 98.0%-102.0%.

Certified Quality: Meets Medicine Grade standards with REACH certification and strict impurity control.

OEM/ODM Support: Manufacturer offers OEM and ODM services with 3 dedicated R&D engineers.

Flexible Payment: Accepts LC, T/T, D/P, PayPal, and Western Union for convenient transactions.

Fast Lead Time: Average lead time is one month for both peak and off-season periods.

Global Export Experience: Established exporter since 2010, serving markets in North America, Europe, and Asia.

Verified Manufacturer: Direct factory with 35 employees, 800 sqm plant, and independent import/export rights.

Precise Specifications: White crystalline powder with CAS 5086-74-8, Assay 99%, and specific melting point.

Company profile

Beijing Mesochem Technology Co., Ltd.

Beijing, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2010-04-01 CertifiedNearest Port: Tianjin PortAverage Response Time: ≤4.51h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryBeijing Mesochem Technology Co., Ltd. is a China-based limited company established in 2009, with 35 employees and reported operations in health, medicine, and chemicals. The supplied information describes two production bases with approximately 67,000 m² of production area and 30,000 L of manufacturing equipment, while another record lists an 800 m² manufacturing plant; this discrepancy should be verified. The supplier reports more than 10 production lines, 6–10 quality-control staff, R&D, pilot, and commercial production capabilities, and product capacity information for several pharmaceutical compounds. It holds ISO 9001:2015 certification and states that its quality system is aligned with FDA, ICH, and EDQM requirements, although FDA review status is not equivalent to approval. Export sales account for 71%–90% of total sales, and three individual trade records identify Everest Pharmaceuticals Limited as a buyer in Bangladesh. Evidence is insufficient to assess after-sales service, customization, and...

Supplier typeThe supplier is identified as a China-based limited company with a combined business-entity type, while one record classifies its company nature as a trading company. Its stated commercial areas include health and medicine and chemicals, and it also reports production bases and manufacturing capabilities, indicating a mixed trading and manufacturing profile.

CertificationsThe supplier reports holding an ISO 9001:2015 certificate and states that its quality assurance system is established to meet FDA, ICH, and EDQM requirements. The slices do not provide certificate scope, validity dates, or evidence of FDA approval, but the stated ISO certification is explicit.

R&D capabilityThe supplier states that it has R&D, pilot-production, and commercial-production capabilities, and reports two ANDAs under FDA review, with more than ten formulations submitted for marketing authorization in multiple regulatory markets. Three R&D engineers are reported, supporting demonstrated development activity, although the depth and success of the innovation program are not fully documented.

Production capacityThe supplier reports two production bases, approximately 67,000 m² of production area, about 30,000 L of equipment, more than 10 production lines, and 6–10 quality-control staff. It also provides product-specific annual productivity entries for adapalene, pimavanserin tartrate, tenofovir alafenamide fumarate, tofacitinib citrate, and lorcaserin hydrochloride. However, the separate 800 m² plant-area record conflicts with the 67,000 m² figure and requires verification.

Client casesThree trade records identify Everest Pharmaceuticals Limited as a buyer for finerenone, velpatasvir, and olaparib, each associated with Bangladesh and one recorded transaction. These records provide concrete customer and product examples, but the limited transaction count does not demonstrate a broad or long-term customer portfolio.